Lv6
1740 积分 2023-03-17 加入
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells
6天前
已完结
Emerging therapeutic strategies in immune thrombocytopenia: an expert evaluation of the evolving treatment landscape
17天前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
19天前
已完结
Second Primary Cancer After Chimeric Antigen Receptor–T-Cell Therapy
20天前
已完结
Refractory ITP: revisiting definitions, diagnostics, and management paradigms
23天前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
3个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
5个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
5个月前
已完结
Mortality, cardiac and cerebral damages reduction by IL-1 inhibition in a murine model of TTP
6个月前
已完结
CD19 chimeric antigen receptor‐T cell therapy in murine immune thrombocytopenia
7个月前
已完结
皖公网安备34019202002308
